ResMed (RMD) Q4 2024 Earnings
RMD·Reported January 30, 2025·After market close·FQ2 FY2025
ResMed reported Q4 2024 revenue of $1.3B, beat analyst consensus of $1.3B by $15.4M. Diluted EPS came in at $2.43, beat the $2.32 consensus by $0.11.
Revenue
$1.3Bbeat by $15.4M
Consensus: $1.3BDiluted EPS
$2.43beat by $0.11
Consensus: $2.32
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about ResMed's Q4 2024 earnings report.
ResMed (RMD) reported Q4 2024 earnings on January 30, 2025 after market close.
ResMed reported revenue of $1.3B and diluted EPS of $2.43 for Q4 2024.
Revenue beat the consensus estimate of $1.3B by $15.4M. EPS beat the consensus estimate of $2.32 by $0.11.
You can read the 10-Q periodic report (0000943819-25-000004) directly on SEC EDGAR. The filing index links above go to sec.gov.